John George Haddad
#138,554
Most Influential Person Now
John George Haddad's AcademicInfluence.com Rankings
John George Haddadbiology Degrees
Biology
#9655
World Rank
#12883
Historical Rank
Biochemistry
#1487
World Rank
#1614
Historical Rank
Download Badge
Chemistry Biology
Why Is John George Haddad Influential?
(Suggest an Edit or Addition)John George Haddad's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- COMPETITIVE PROTEIN-BINDING RADIOASSAY FOR 25-HYDROXYCHOLECALCIFEROL1 (1971) (807)
- Effect of testosterone treatment on bone mineral density in men over 65 years of age. (1999) (771)
- Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. (1986) (552)
- Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. (1999) (362)
- Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. (1972) (334)
- Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. (1984) (309)
- Racial pigmentation and the cutaneous synthesis of vitamin D. (1991) (308)
- Human plasma transport of vitamin D after its endogenous synthesis. (1993) (264)
- Competitive protein-binding radioassay for 25-hydroxycholecalciferol. (1971) (253)
- Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. (1985) (248)
- 25-hydroxycholecalciferol stimulation of muscle metabolism. (1975) (243)
- Natural and Synthetic Sources of Circulating 25-Hydroxyvitamin D in Man (1973) (233)
- Serum 25-Hydroxycalciferol Levels and Bone Mass in Children on Chronic Anticonvulsant Therapy (1975) (218)
- Vitamin D binding protein (Gc-globulin). (1989) (206)
- Plasma Levels and Therapeutic Effect of 25-Hydroxycholecalciferol in Epileptic Patients taking Anticonvulsant Drugs (1972) (203)
- Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. (1996) (195)
- Human perinatal vitamin D metabolism. I. 25-Hydroxyvitamin D in maternal and cord blood. (1974) (191)
- COMPARISON OF ORAL 25-HYDROXYCHOLECALCIFEROL, VITAMIN D, AND ULTRAVIOLET LIGHT AS DETERMINANTS OF CIRCULATING 25-HYDROXYVITAMIN D (1977) (191)
- 25-Hydroxyvitamin D transport in human plasma. Isolation and partial characterization of calcifidiol-binding protein. (1976) (183)
- Angiopathic consequences of saturating the plasma scavenger system for actin. (1990) (183)
- Circulating 25-hydroxyvitamin D in man. (1974) (157)
- Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiency. (1985) (154)
- Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. (1986) (150)
- Plasma vitamin D-binding protein (Gc-globulin): Multiple tasks (1995) (149)
- Perinatal vitamin D metabolism (1975) (127)
- Radioimmunoassay of the binding protein for vitamin D and its metabolites in human serum: concentrations in normal subjects and patients with disorders of mineral homeostasis. (1976) (121)
- Acute administration of 25-hydroxycholecalciferol in man. (1976) (118)
- Serial Measurements of Serum Calcium, Magnesium, Parathyroid Hormone, Calcitonin, and 25-Hydroxy-Vitamin D in Premature and Term Infants during the First Week of Life (1977) (110)
- Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McCune-Albright syndrome). (1988) (110)
- In vivo threshold for cutaneous synthesis of vitamin D3. (1989) (104)
- Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog. (1977) (99)
- Bone disease in burn patients (1993) (96)
- Vitamin D bioavailability: serum 25-hydroxyvitamin D levels in man after oral, subcutaneous, intramuscular, and intravenous vitamin D administration. (1979) (95)
- Widespread, specific binding of 25-hydroxycholecalciferol in rat tissues. (1975) (94)
- Competitive protein-binding radioassay of 24,25-dihydroxyvitamin D in sera from normal and anephric subjects. (1977) (89)
- Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins. (1972) (86)
- Placental transfer of vitamin D3 and 25-hydroxycholecalciferol in the rat. (1971) (85)
- Human serum binding protein for vitamin D and its metabolites (DBP): evidence that actin is the DBP binding component in human skeletal muscle. (1982) (82)
- Perinatal vitamin D metabolism. IV. Maternal and cord serum 24,25-dihydroxyvitamin D concentrations. (1978) (82)
- Vitamin D--solar rays, the Milky Way, or both? (1992) (79)
- Serum 25-hydroxyvitamin D concentrations in patients receiving chronic corticosteroid therapy. (1977) (76)
- Abnormalities of circulating 25-OH vitamin D after jejunal-lleal bypass for obesity: evidence of an adaptive response. (1977) (73)
- Vitamin D plasma binding protein. Turnover and fate in the rabbit. (1981) (72)
- Brevin and vitamin D binding protein: comparison of the effects of two serum proteins on actin assembly and disassembly. (1984) (71)
- Human serum binding capacity and affinity for 25-hydroxyergocalciferol and 25-hydroxycholecalciferol. (1976) (71)
- Effects of prolonged thyrocalcitonin administration on Paget's disease of bone. (1970) (70)
- Identification of the sterol- and actin-binding domains of plasma vitamin D binding protein (Gc-globulin). (1992) (70)
- Interactions among serum vitamin D binding protein, monomeric actin, profilin, and profilactin. (1989) (68)
- Control of mineral homeostasis during lactation: interrelationships of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, 1,25-dihydroxyvitamin D, parathyroid hormone, calcitonin, prolactin, and estradiol. (1981) (64)
- Serum concentrations of 25-hydroxyvitamin D in sex-linked hypophosphatemic vitamin D-resistant rickets. (1973) (59)
- Human serum binding protein for vitamin D and its metabolites. II. Specific, high affinity association with a protein in nucleated tissue. (1979) (58)
- Perinatal vitamin D metabolism. III. Factors influencing late gestational human serum 25-hydroxyvitamin D. (1976) (58)
- Competition by 24,25-dihydroxycholecalciferol in the competitive protein binding radioassay of 25-hydroxycalciferol. (1976) (57)
- 25-Hydroxycholecalciferol-binding globulin in human plasma (1971) (56)
- Vitamin D deficiency in homebound elderly persons (1996) (56)
- Pathogenic mechanisms of the hypocalcemia of the staphylococcal toxic-shock syndrome. (1983) (55)
- Serum concentration of 25-hydroxyvitamin D in rickets of extremely premature infants (1979) (53)
- Osteopetrorickets. The paradox of plenty. Pathophysiology and treatment. (1993) (53)
- Vitamin D metabolite-binding proteins in human tissue. (1976) (53)
- Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin. (1974) (52)
- Hypocalcemia and skeletal disease as presenting features of celiac disease. (1997) (51)
- Vitamin D binding protein sequesters monomeric actin in the circulation of the rat. (1987) (51)
- Regional migratory osteoporosis. A case report and review of the literature. (1990) (51)
- Mineral homeostasis in very premature infants: serial evaluation of serum 25-hydroxyvitamin D, serum minerals, and bone mineralization. (1985) (49)
- Nondialyzable urinary hydroxyproline as an index of bone collagen formation. (1970) (47)
- Disruption of microfilament organization in living nonmuscle cells by microinjection of plasma vitamin D-binding protein or DNase I. (1990) (47)
- Human serum binding protein for vitamin D and its metabolites. I. Physicochemical and immunological identification in human tissues. (1979) (47)
- "Rocket" immunoelectrophoresis assay of vitamin D-binding protein (Gc globulin) in human serum. (1982) (46)
- Characterization of a monoclonal antibody to human serum vitamin D binding protein (Gc globulin): recognition of an epitope hidden in membranes of circulating monocytes. (1986) (45)
- Transport of vitamin D metabolites. (1979) (40)
- Osteoporosis and hip fracture in a young woman with anorexia nervosa. (1986) (39)
- Detection of vitamin D binding protein on the surface of cytotrophoblasts isolated from human placentae. (1987) (36)
- Hepatic accumulation of vitamin D3 and 25-hydroxyvitamin D3. (1976) (36)
- Perinatal vitamin D metabolism. II. Serial 25-hydroxyvitamin D concentrations in sera of term and premature infants. (1975) (35)
- Osteomalacia and osteitis fibrosa in a man ingesting aluminum hydroxide antacid. (1984) (34)
- Skeletal Abnormalities After Jejunoileal Bypass (1979) (32)
- Cell surface vitamin D-binding protein (GC-globulin) is acquired from plasma. (1990) (32)
- Actin affinity chromatography in the purification of human, avian and other mammalian plasma proteins binding vitamin D and its metabolites (Gc globulins). (1984) (31)
- Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells. (1991) (30)
- Absorption, dosage, and effect on mineral homeostasis of 25-hydroxycholecalciferol in premature infants: comparison with 400 and 800 IU vitamin D2 supplementation. (1985) (28)
- Glucocorticoid effects in vitamin D intoxication. (1979) (28)
- Skin types and epidermal photosynthesis of vitamin D3. (1990) (28)
- Normal rabbit intestinal cytosol as a source of binding protein for the 1,25-dihydroxyvitamin D3 assay. (1983) (28)
- Successful treatment of infantile malignant osteopetrosis by bone-marrow transplantation. A case report. (1988) (27)
- Circulating phytosterols in normal females, lactating mothers and breast cancer patients. (1970) (27)
- Parathyroid hormone status and renal responsiveness in familial hypophosphatemic rickets. (1975) (27)
- Transport and metabolism of vitamins. (1986) (25)
- Ontogeny and effect of vitamin D deprivation on rat serum 25-hydroxyvitamin D binding protein. (1977) (25)
- Primary hyperparathyroidism with low serum 1,25-dihydroxyvitamin D levels. (1986) (25)
- Vitamin D uptake and metabolism by perfused rat liver: influences of carrier proteins. (1988) (25)
- Receptors for and bioresponses to 1,25-dihydroxyvitamin D in a human colon carcinoma cell line (HT-29). (1989) (24)
- 25-Hydroxycholecalciferol: specific binding by rachitic tissue extracts. (1971) (23)
- Vitamin D metabolites. Specific binding by rat intestinal cytosol. (1973) (22)
- A possible new role for vitamin D-binding protein in osteoclast control: inhibition of extracellular Ca2+ sensing at low physiological concentrations. (1998) (22)
- Estrogen receptors in fracture healing. (1992) (19)
- Paget's disease. (1983) (19)
- Serum concentrations of 25-hydroxyvitamin D in rickets of extremely premature infants. (1979) (18)
- Postnatal fall and rise of circulating 25-hydroxyvitamin D in the rat*. (1975) (17)
- Nature and Functions of the Plasma Binding Protein for Vitamin D and its Metabolites (1984) (17)
- The cluster phenomenon in patients who have multiple vertebral compression fractures. (1993) (17)
- Serial analyses of serum vitamin D-binding protein in preterm infants from birth to postconceptual maturity. (1983) (17)
- Paget bone disease: radiologic documentation of healing with human calcitonin therapy. (1980) (16)
- Affinity chromatography with 25-hydroxycholecalciferol ester in the isolation of the binding protein for vitamin D and its metabolites from human serum. (1981) (16)
- Human calcitonin radioimmunoassay: characterization and application. (1977) (16)
- Bone densitometry observations of osteopetrosis in response to bone marrow transplantation. (1993) (15)
- Phosphorus deprivation: the metabolism of vitamin D 3 and 25-hydroxycholecalciferol in rats. (1972) (15)
- Post‐transcriptional stimulation of transforming growth factor β1 mRNA by TGF‐β1 treatment of transformed human osteoblasts (1996) (13)
- The Vitamin D Binding Protein and Its Clinical Significance (1999) (13)
- The vitamin D family revisited. (1984) (13)
- Healing of lytic Paget bone disease with diphosphonate therapy. (1980) (12)
- Skeletal response to immobilization in Paget's disease of bone: a case report. (1996) (12)
- Selective, rapid removal of the vitamin D-binding protein and its sterol ligands from human and bovine plasma. (1985) (11)
- Quantitative computed tomography reflects vertebral fracture morbidity in osteopenic patients. (1989) (11)
- Lymphoma, Hypercalcemia, and the Sunshine Vitamin (1994) (10)
- Multiple pathologic fractures of the appendicular skeleton in a patient with Cushing's disease. (1987) (10)
- Spontaneous healing of jejunoileal bypass-induced osteomalacia. (1989) (10)
- Extraction of vitamin D metabolites by bones of normal adult dogs. (1982) (10)
- Ontogenesis of the rabbit intestinal receptor for 1,25-dihydroxyvitamin D3--evidence for increased receptor content during late suckling and lactating periods. (1984) (10)
- TURNOVER AND FATE IN THE RABBIT (1981) (10)
- Characterization of the human plasma binding protein for vitamin D and its metabolites synthesized by the human hepatoma-derived cell line, Hep 3B. (1983) (10)
- Serum 25-hydroxyvitamin D concentrations in sudden infant death syndrome. (1980) (10)
- Paget's disease: Complications and controversies (1994) (9)
- Elevation of blood vitamin D2 levels does not impede the release of vitamin D3 from the skin. (1992) (9)
- Severe Symptomatic Osteopenia in a Man With Pigmented Micronodular Adrenal Hyperplasia (1995) (9)
- Osteomalacia in a night nurse. (1986) (9)
- Monoclonal antibody with high affinity for 1,25-dihydroxycholecalciferol. (1983) (8)
- A case of idiopathic hypoparathyroidism and dietary vitamin D deficiency: the requirement for calcium and vitamin D for bone, but not renal responsiveness to PTH. (1977) (8)
- Electrophoretic mobility shift assay identifies vitamin D binding protein (Gc-globulin) in human, rat, and mouse sera. (1996) (8)
- Plasma carriers influence the uptake of cholecalciferol by human hepatoma‐derived cells (1989) (7)
- Variable potency of intramuscular vitamin D preparations. (1979) (7)
- Vitamin D binding proteins. (1982) (7)
- 1,25‐Dihydroxyvitamin D3 Stimulates Interieukin‐2 Production by a T Cell Lymphoma Line (MLA‐144) Cultured in Vitamin D‐Deficient Rat Serum (1987) (7)
- Medical reversal of acquired hypophosphatemic osteomalacia. (1987) (7)
- Osteomalacia as a very late manifestation of primary hyperparathyroidism. (1988) (7)
- Cutaneous formation of vitamin D in psoriasis. (1990) (6)
- Vitamin D in clinical medicine. (1983) (6)
- Post-transcriptional stimulation of transforming growth factor beta 1 mRNA by TGF-beta 1 treatment of transformed human osteoblasts. (1996) (6)
- Comparative effects of phosphate and thyrocalcitonin on skeletal turnover. (1970) (6)
- The articular manifestations of Paget's disease of bone. A case report. (1992) (5)
- Effect of oral vitamin D, 25-hydroxycholecalciferol (25-HCC) and whole-body ultra-violet irradiation on plasma 25-HCC levels in man. (1973) (5)
- Hypocalcemia and other abnormalities of mineral homeostasis during the neonatal period (1982) (5)
- Vitamin D's: more and more measured better and better. (1977) (5)
- [53] Purification, characterization, and quantitation of the human serum binding protein for vitamin D and its metabolites (1980) (5)
- Assay of Vitamin D and its Metabolites (1976) (4)
- Serum calcitonin concentrations in premature infants during the first 12 weeks of life (1982) (4)
- In vitro insulinogenic effect of material harvested from incubated gut loops of rats. (1969) (4)
- Survey of Competition Assays for the Vitamin D Metabolites (1983) (4)
- Progress in endocrinology and metabolism. Vitamin D: current concepts. (1973) (3)
- Vitamin D economy in gastrointestinal disease. (1977) (3)
- Seasonal diminution of vitamin D stores in the United States. Can darker winters lead to lighter bones? (1996) (3)
- The treatment of Paget's disease of bone. Hobson's choice? (1969) (2)
- Paget's disease of bone: problems and management. (1972) (2)
- Vitamin D transport - the nature of the interaction between plasma DBP and tissue protein. (1980) (2)
- 859 SERUM 24,25 DIHYDROXY VITAMIN D CONCENTRATIONS IN LACTATING AND NON-LACTATING POST PARTUM WOMEN (1978) (1)
- 21 – Vitamin D Metabolites (1978) (1)
- Failure of calcium (Ca) and phosphorus (P) supplementation to correct low serum 25-hydroxyvitamin D (25-OHD) concentrations in premature infants. (1980) (1)
- 1133 SERUM VITAMIN D BINDING PROTEIN (DBP) IN PRETERM INFANTS (1981) (1)
- 25 Hydroxycholecalciferol (25 OHD3) stimulates rat muscle protein synthesis (1975) (1)
- Inherited and acquired disorders of vitamin D metabolism. (1982) (1)
- Modelling and Testing Aluminum Based High Entropy Alloys (2018) (1)
- 301 SERIAL CALCITONIN SERUM CONCENTRATIONS IN PREMATURE INFANTS DURING THE FIRST 12 WEEKS OF LIFE (1978) (1)
- Bone disease in burn patients: Roles of aluminum and bed rest (1992) (1)
- Estrogen Receptors in Bonein a Patient with Pol ycystic Fibrous Dysplasia(McCune-Albrig ht Syndrome) (1989) (0)
- Osteoporosis in Men (1997) (0)
- Osteoporosis in men. (1997) (0)
- Reactivation of healed osteolytic Paget's bone disease following cessation of synthetic human calcitonin therapy (1981) (0)
- Preventing actin interference in immunonephelometric measurements of vitamin D-binding protein (Gc-globulin). (1995) (0)
- Assay for 1,25-dihydroxyvitamin D using rabbit intestinal cytosol-binding protein. (1986) (0)
- Paget's disease of bone. (1994) (0)
- Calcium disorders in childhood. (1983) (0)
- Regulation of serum 24,25 dihydroxyvitamin d (24,25) in man (1977) (0)
- Abnormalities of Circulating 25-OH Vitamin D after Jejunal-Ileal Bypass for Obesity (2020) (0)
- Extraction ofVitamin D Metabolites byBonesofNormalAdultDogs (1981) (0)
- PLASMA VITAMIN D BINDING PROTEIN: PLASMA SCAVENGER FUNCTION AND ORIGIN OF CELL-SURFACE DBP. (1988) (0)
- Experiences with Human Calcitonin in the Treatment of Paget’s Disease of Bone (1991) (0)
- LOW SERUM CALCITRIOL CONCENTRATIONS AND REDUCED BONE FORMATION IN PATIENTS WITH SEVERE BURNS (1991) (0)
- 10 Questions Commonly Asked by Physicians about Osteoporosis (1996) (0)
- Purification, characterization, and quantitation of the human serum binding protein for vitamin D and its metabolites. (1980) (0)
- Vitamin D Assessment: The Assays and Their Applications (1981) (0)
- Syndromes of Vitamin D Resistance (1997) (0)
- pneumonia outbreak in the intensive care unit (ICU) traced to a manual weaning criteria machine (1993) (0)
- 437 SERUM 25-HYDROXY-VITAMIN D (25-OHD) CONCENTRATIONS AND BONE HISTOLOGY IN SUDDEN INFANT DEATH SYNDROME (SIDS) (1978) (0)
- MATERNAL AND CORD SERUM CONCENTRATIONS OF 24,25-DIHYDROXYVITAMIN D (24,25-(OH)2D) (1977) (0)
- The Jewish Hospital of St. Louis therapeutic grand rounds no. 13. Cushing disease. (1976) (0)
- Role of Growth Hormone in the Treatment of Postmenopausal Osteoporosis (1995) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With John George Haddad?
John George Haddad is affiliated with the following schools:
